Timing and Efficacy of 595-nm Pulsed-Dye Laser Combined with 0.5% Timolol Maleate Solution in the Treatment of Superficial Infantile Hemangiomas

References

• Munden A, Butschek R, Tom W, et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014;170(4):907–913. doi:10.1111/bjd.12804
   PubMed Web of Science ®Google Scholar
• Goelz R, Poets C. Incidence and treatment of infantile haemangioma in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2015;100(1):F85–F91. doi:10.1136/archdischild-2014-306197
   PubMed Web of Science ®Google Scholar
• Chang L, Haggstrom A, Drolet B, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008;122(2):360–367. doi:10.1542/peds.2007-2767
   PubMed Web of Science ®Google Scholar
• Hoeger P, Harper J, Baselga E, et al. Treatment of infantile haemangiomas: recommendations of a European expert group. Eur J Pediatr. 2015;174(7):855–865. doi:10.1007/s00431-015-2570-0
   PubMed Web of Science ®Google Scholar
• Bauland C, Lüning T, Smit J, Zeebregts C, Spauwen P. Untreated hemangiomas: growth pattern and residual lesions. Plast Reconstr Surg. 2011;127(4):1643–1648. doi:10.1097/PRS.0b013e318208d2ac
   PubMed Web of Science ®Google Scholar
• Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol. 2011;25(11):1245–1253. doi:10.1111/j.1468-3083.2011.04102.x
   PubMed Web of Science ®Google Scholar
• Enjolras O, Mulliken J. The current management of vascular birthmarks. Pediatr Dermatol. 1993;10(4):311–313. doi:10.1111/j.1525-1470.1993.tb00393.x
   Web of Science ®Google Scholar
• Chen W, Liu S, Yang C, Yang S. Clinical efficacy of the 595 nm pulsed dye laser in the treatment of childhood superficial hemangioma - analysis of 10-year application in Chinese patients. J Dermatolog Treat. 2015;26(1):54–58. doi:10.3109/09546634.2013.806979
   PubMed Web of Science ®Google Scholar
• Chelleri C, Monzani N, Gelmetti C, et al. Residual lesions after pharmacological and dye-laser treatment of infantile hemangiomas: critical review of 432 cases. Lasers Surg Med. 2020;52(7):597–603. doi:10.1002/lsm.23205
   Web of Science ®Google Scholar
• Moyakine A, Spillekom-van Koulil S, van der Vleuten C. Propranolol treatment of infantile hemangioma is not associated with psychological problems at 7 years of age. J Am Acad Dermatol. 2017;77(1):105–108. doi:10.1016/j.jaad.2017.01.025
   Web of Science ®Google Scholar
• Moyakine A, Hermans D, Fuijkschot J, van der Vleuten C. Propranolol treatment of infantile hemangiomas does not negatively affect psychomotor development. J Am Acad Dermatol. 2015;73(2):341–342. doi:10.1016/j.jaad.2015.04.053
   PubMed Web of Science ®Google Scholar
• Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo J, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649–2651. doi:10.1056/NEJMc0708819
   PubMed Web of Science ®Google Scholar
• Cheng C, Friedlander S. Infantile hemangiomas, complications and treatments. Semin Cutan Med Surg. 2016;35(3):108–116. doi:10.12788/j.sder.2016.050
   Web of Science ®Google Scholar
• Calvo M, Garcia-Millán C, Villegas C, Fueyo-Casado A, Burón I. Topical timolol for infantile hemangioma of the eyelid. Int J Dermatol. 2013;52(5):603–604. doi:10.1111/j.1365-4632.2011.05290.x
   Web of Science ®Google Scholar
• Püttgen K, Lucky A, Adams D, et al. Topical timolol maleate treatment of infantile hemangiomas. Pediatrics. 2016;138(3). doi:10.1542/peds.2016-0355
   Web of Science ®Google Scholar
• Frommelt P, Juern A, Siegel D, et al. Adverse events in young and preterm infants receiving topical timolol for infantile hemangioma. Pediatr Dermatol. 2016;33(4):405–414. doi:10.1111/pde.12869
   PubMed Web of Science ®Google Scholar
• Chakkittakandiyil A, Phillips R, Frieden I, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol. 2012;29(1):28–31. doi:10.1111/j.1525-1470.2011.01664.x
   PubMed Web of Science ®Google Scholar
• Ovadia S, Landy D, Cohen E, Yang E, Thaller S. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis. Ann Plast Surg. 2015;74(2):256–262. doi:10.1097/sap.0000000000000390
   PubMed Web of Science ®Google Scholar
• Batta K, Goodyear H, Moss C, Williams H, Hiller L, Waters R. Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet. 2002;360(9332):521–527. doi:10.1016/s0140-6736(02)09741-6
   Web of Science ®Google Scholar
• Chen Z, Wang Q, Zhu Y, et al. Progress in the treatment of infantile hemangioma. Ann Transl Med. 2019;7(22):692. doi:10.21037/atm.2019.10.47
   PubMed Web of Science ®Google Scholar
• Ying H, Zou Y, Yu W, et al. Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser. J Dermatol. 2017;44(6):660–665. doi:10.1111/1346-8138.13747
   PubMed Web of Science ®Google Scholar
• Rizzo C, Brightman L, Chapas A, et al. Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling: a retrospective chart analysis. Dermatol Surg. 2009;35(12):1947–1954. doi:10.1111/j.1524-4725.2009.01356.x
   Web of Science ®Google Scholar
• Poetke M, Philipp C, Berlien H. Flashlamp-pumped pulsed dye laser for hemangiomas in infancy: treatment of superficial vs mixed hemangiomas. Arch Dermatol. 2000;136(5):628–632. doi:10.1001/archderm.136.5.628
   PubMedGoogle Scholar
• Zide B, Levine S. Hemangioma update: pearls from 30 years of treatment. Ann Plast Surg. 2012;69(1):99–103. doi:10.1097/SAP.0b013e3182212881
   Web of Science ®Google Scholar
• Park K, Jang Y, Chung H, Lee W, Kim D, Lee S. Topical timolol maleate 0.5% for infantile hemangioma; it’s effectiveness and/or adjunctive pulsed dye laser - single center experience of 102 cases in Korea. J Dermatolog Treat. 2015;26(4):389–391. doi:10.3109/09546634.2014.990412
   PubMed Web of Science ®Google Scholar
• Hunzeker C, Geronemus R. Treatment of superficial infantile hemangiomas of the eyelid using the 595-nm pulsed dye laser. Dermatologic surgery : official publication for American Society for Dermatologic Surgery. 2010;36(5): 590–597. doi:10.1111/j.1524-4725.2010.01511.x
   Google Scholar
• Chen X, Guo Y, Wang P, et al. Efficacy and safety of adrenergic beta-antagonist combined with lasers in the treatment of infantile hemangiomas: a meta-analysis. Pediatr Surg Int. 2020;36(10):1135–1147. doi:10.1007/s00383-020-04711-2
   Web of Science ®Google Scholar